Description Designed for the prevention of avian influenza in both disease-free and affected poultry farms. The vaccine is produced from the H5N1 virus, cultivated in chicken embryos or FEC cell cultures, and inactivated with formalin. It is emulsified with an oil-based adjuvant in a 40:60 ratio.
Target Animals:
All poultry species
Immunity and Dosage Method of use:injections. Adult birds:
From 3 weeks of age — 0.5 ml subcutaneously.
Revaccination — 4 weeks before the start of egg-laying, then once annually.